1-11 of 11
Amro Aboukameel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers

Open Access
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Md. Hafiz Uddin, Sahar F. Bannoura, Yousef Mzannar, Ibrahim Azar, Eliza W. Beal, Miguel E. Tobon, Steve H. Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F. El-Rayes, Philip A. Philip, Ramzi M. Mohammad, Anthony F. Shields, Mohammed Najeeb Al Hallak, Asfar S. Azmi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12): 1422–1433.
https://doi.org/10.1158/1535-7163.MCT-23-0251
Published: 01 December 2023
View articletitled, Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers
Open the PDF for Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers in another window
Includes: Supplementary data
Journal Articles

PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus

Available to Purchase
Gabriel B. Mpilla, Md. Hafiz Uddin, Mohammed N. Al-Hallak, Amro Aboukameel, Yiwei Li, Steve H. Kim, Rafic Beydoun, Gregory Dyson, Erkan Baloglu, William T. Senapedis, Yosef Landesman, Kay-Uwe Wagner, Nerissa T. Viola, Bassel F. El-Rayes, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (10): 1836–1845.
https://doi.org/10.1158/1535-7163.MCT-20-1105
Published: 01 October 2021
View articletitled, PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus
Open the PDF for PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus in another window
Includes: Supplementary data
Journal Articles

Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma

Available to Purchase
Amro Aboukameel, Irfana Muqbil, William Senapedis, Erkan Baloglu, Yosef Landesman, Sharon Shacham, Michael Kauffman, Philip A. Philip, Ramzi M. Mohammad, Asfar S. Azmi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (1): 76–87.
https://doi.org/10.1158/1535-7163.MCT-16-0205
Published: 05 January 2017
View articletitled, Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma
Open the PDF for Novel p21-Activated Kinase 4 (PAK4) Allosteric Modulators Overcome Drug Resistance and Stemness in Pancreatic Ductal Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo

Available to Purchase
Fardokht Abulwerdi, Chenzhong Liao, Meilan Liu, Asfar S. Azmi, Amro Aboukameel, Ahmed S.A. Mady, Thippeswamy Gulappa, Tomasz Cierpicki, Scott Owens, Tao Zhang, Duxin Sun, Jeanne A. Stuckey, Ramzi M. Mohammad, Zaneta Nikolovska-Coleska
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (3): 565–575.
https://doi.org/10.1158/1535-7163.MCT-12-0767
Published: 09 March 2014
View articletitled, A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Open the PDF for A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo in another window
Includes: Supplementary data
Journal Articles

Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells

Available to Purchase
Aamir Ahmad, Sanila H. Sarkar, Bassam Bitar, Shadan Ali, Amro Aboukameel, Seema Sethi, Yiwei Li, Bin Bao, Dejuan Kong, Sanjeev Banerjee, Subhash B. Padhye, Fazlul H. Sarkar
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (10): 2193–2201.
https://doi.org/10.1158/1535-7163.MCT-12-0232-T
Published: 09 October 2012
View articletitled, Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells
Open the PDF for Garcinol Regulates EMT and Wnt Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity against Breast Cancer Cells in another window
Journal Articles

Adamantyl-Substituted Retinoid-Related Molecules Induce Apoptosis in Human Acute Myelogenous Leukemia Cells

Available to Purchase
Lulu Farhana, Marcia I. Dawson, Zebin Xia, Amro Aboukameel, Liping Xu, Gang Liu, Jayanta K. Das, James Hatfield, Edi Levi, Ramzi Mohammad, Joseph A. Fontana
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (11): 2903–2913.
https://doi.org/10.1158/1535-7163.MCT-10-0546
Published: 09 November 2010
View articletitled, Adamantyl-Substituted Retinoid-Related Molecules Induce Apoptosis in Human Acute Myelogenous Leukemia Cells
Open the PDF for Adamantyl-Substituted Retinoid-Related Molecules Induce Apoptosis in Human Acute Myelogenous Leukemia Cells in another window
Journal Articles

ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells

Available to Purchase
Jyoti Nautiyal, Yingjie Yu, Amro Aboukameel, Shailender S. Kanwar, Jayanta K. Das, Jianhua Du, Bhaumik B. Patel, Fazlul H. Sarkar, Arun K. Rishi, Ramzi M. Mohammad, Adhip P.N. Majumdar
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (6): 1503–1514.
https://doi.org/10.1158/1535-7163.MCT-10-0019
Published: 09 June 2010
View articletitled, ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells
Open the PDF for ErbB-Inhibitory Protein: A Modified Ectodomain of Epidermal Growth Factor Receptor Synergizes with Dasatinib to Inhibit Growth of Breast Cancer Cells in another window
Includes: Supplementary data
Journal Articles

Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells

Available to Purchase
KM Wahidur Rahman, Shadan Ali, Amro Aboukameel, Sanila H. Sarkar, Zhiwei Wang, Philip A. Philip, Wael A. Sakr, Avraham Raz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2757–2765.
https://doi.org/10.1158/1535-7163.MCT-07-0336
Published: 15 October 2007
View articletitled, Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells
Open the PDF for Inactivation of NF-κB by 3,3′-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells in another window
Journal Articles

Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo

Available to Purchase
Liyue Zhang, Edi Levi, Pralay Majumder, Yingjie Yu, Amro Aboukameel, Jianhua Du, Hu Xu, Ramzi Mohammad, James S. Hatfield, Anil Wali, Volkan Adsay, Adhip P.N. Majumdar, Arun K. Rishi
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (5): 1661–1672.
https://doi.org/10.1158/1535-7163.MCT-06-0653
Published: 18 May 2007
View articletitled, Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo
Open the PDF for Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo in another window
Journal Articles

Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(−)-gossypol] against diffuse large cell lymphoma

Available to Purchase
Ramzi M. Mohammad, Shaomeng Wang, Amro Aboukameel, Ben Chen, Xihan Wu, Jianyong Chen, Ayad Al-Katib
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (1): 13–21.
https://doi.org/10.1158/1535-7163.13.4.1
Published: 18 January 2005
View articletitled, Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(−)-gossypol] against diffuse large cell lymphoma
Open the PDF for Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(−)-gossypol] against diffuse large cell lymphoma in another window
Journal Articles

Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy

Available to Purchase
Ramzi M. Mohammad, Ayad Al-Katib, Amro Aboukameel, Daniel R. Doerge, Fazlul Sarkar, Omer Kucuk
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2003) 2 (12): 1361–1368.
Published: 05 January 2004
View articletitled, Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy
Open the PDF for Genistein sensitizes diffuse large cell lymphoma to CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) chemotherapy in another window